Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Current Assets (2016 - 2021)

Historic Current Assets for Neurocrine Biosciences (NBIX) over the last 12 years, with Q3 2021 value amounting to $1.0 billion.

  • Neurocrine Biosciences' Current Assets fell 1306.94% to $1.0 billion in Q3 2021 from the same period last year, while for Sep 2021 it was $1.0 billion, marking a year-over-year decrease of 1306.94%. This contributed to the annual value of $1.0 billion for FY2020, which is 2228.64% up from last year.
  • As of Q3 2021, Neurocrine Biosciences' Current Assets stood at $1.0 billion, which was down 1306.94% from $1.1 billion recorded in Q2 2021.
  • Neurocrine Biosciences' 5-year Current Assets high stood at $1.2 billion for Q3 2020, and its period low was $239.5 million during Q1 2017.
  • Its 5-year average for Current Assets is $786.0 million, with a median of $748.8 million in 2019.
  • Per our database at Business Quant, Neurocrine Biosciences' Current Assets tumbled by 4028.42% in 2017 and then surged by 11453.91% in 2018.
  • Neurocrine Biosciences' Current Assets (Quarter) stood at $554.9 million in 2017, then surged by 32.95% to $737.8 million in 2018, then grew by 12.64% to $831.0 million in 2019, then grew by 22.29% to $1.0 billion in 2020, then decreased by 1.03% to $1.0 billion in 2021.
  • Its last three reported values are $1.0 billion in Q3 2021, $1.1 billion for Q2 2021, and $1.1 billion during Q1 2021.